Here are five things to know about the transaction:
1. Mr. Cole sold 40,367 shares at $17.86 per share, average price.
2. The total value of the transaction was $720,954.62.
3. Mr. Cole now directly owns 308 shares of the company, valued at around $5,500.88.
4. K2M traded up yesterday, hitting $19.85 per share.
5. The company’s market cap is $783.4 million.
More articles on orthopedic devices:
OsteoMed launches ankle fusion plating system
Mesoblast gets patent for mesenchymal precursor cell technology—7 things to know
K2M closes follow-on offering with $35M
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
